Waddah A Alrefai Selected Research

Chloride-Bicarbonate Antiporters

1/2020	All-trans Retinoic Acid Counteracts Diarrhea and Inhibition of Downregulated in Adenoma Expression in Gut Inflammation.
12/2019	Decreased SLC26A3 expression and function in intestinal epithelial cells in response to Cryptosporidium parvum infection.
11/2016	Lactobacillus acidophilus counteracts inhibition of NHE3 and DRA expression and alleviates diarrheal phenotype in mice infected with Citrobacter rodentium.
1/2016	Transcriptional modulation of SLC26A3 (DRA) by sphingosine-1-phosphate.
12/2015	Mechanisms of DRA recycling in intestinal epithelial cells: effect of enteropathogenic E. coli.
12/2015	Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea.
1/2014	Translational repression of SLC26A3 by miR-494 in intestinal epithelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Waddah A Alrefai Research Topics

Disease

20	Diarrhea 01/2020 - 09/2002
16	Adenoma (Adenomas) 01/2021 - 11/2007
13	Inflammation (Inflammations) 01/2021 - 11/2008
10	Infections 01/2021 - 12/2009
9	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 09/2002
4	Colitis 01/2020 - 06/2011
4	Diabetes Mellitus 03/2019 - 10/2010
3	Hypercholesterolemia 01/2013 - 10/2010
2	Dysbiosis 01/2021 - 01/2019
2	Non-alcoholic Fatty Liver Disease 01/2020 - 11/2017
2	Fibrosis (Cirrhosis) 01/2020 - 11/2017
2	Crohn Disease (Crohn's Disease) 01/2020 - 05/2007
2	Fatty Liver 12/2019 - 11/2017
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 03/2019 - 12/2009
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 07/2017 - 04/2011
1	Alcoholic Fatty Liver 01/2020
1	Ileitis 01/2020
1	Ulcerative Colitis 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 12/2019
1	Colonic Neoplasms (Colon Cancer) 03/2019
1	Kidney Calculi (Kidney Stone) 01/2019
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Neoplasms (Cancer) 01/2018
1	Salmonella Infections (Salmonellosis) 01/2018
1	Carcinogenesis 01/2018
1	Insulin Resistance 04/2016
1	Cysts 01/2015
1	Communicable Diseases (Infectious Diseases) 03/2012
1	Thyroid Neoplasms (Thyroid Cancer) 12/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2010
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 04/2010
1	Necrotizing Enterocolitis 04/2010
1	Dysentery 12/2009

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2010
8	Messenger RNA (mRNA)IBA 03/2020 - 12/2009
7	AnionsIBA 01/2021 - 11/2007
7	Chloride-Bicarbonate AntiportersIBA 01/2020 - 01/2014
7	CholesterolIBA 01/2020 - 10/2010
6	Bile Acids and Salts (Bile Acids)IBA 12/2019 - 05/2007
5	CytokinesIBA 01/2020 - 10/2008
5	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 04/2005
5	ElectrolytesIBA 01/2018 - 03/2010
5	Phenobarbital (Luminal)FDA Link 09/2017 - 01/2015
4	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2019 - 12/2009
4	hydroxide ionIBA 02/2010 - 09/2002
3	ChloridesIBA 01/2021 - 11/2007
3	LipidsIBA 01/2020 - 11/2017
3	Dextran SulfateIBA 01/2020 - 06/2011
3	Drinking WaterIBA 01/2020 - 06/2011
2	Volatile Fatty AcidsIBA 01/2021 - 10/2015
2	Dietary Fiber FDA Link 01/2021 - 10/2015
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2020 - 06/2011
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020 - 06/2015
2	Peroxidase (Myeloperoxidase)IBA 01/2020 - 06/2011
2	Hormones (Hormone)IBA 12/2019 - 04/2016
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018 - 04/2010
2	Protein Tyrosine PhosphatasesIBA 05/2017 - 12/2009
2	AntidiarrhealsIBA 11/2016 - 03/2012
2	Butyrates (Butyrate)IBA 10/2015 - 11/2012
1	Tight Junction ProteinsIBA 01/2021
1	4-(4-sulfophenylazo)-2-mercuriphenol (SAMP)IBA 01/2020
1	MicronutrientsIBA 01/2020
1	InterferonsIBA 01/2020
1	4,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA 12/2019
1	OxalatesIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2018
1	Tryptophan (L-Tryptophan)FDA Link 01/2018
1	XenobioticsIBA 01/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2018
1	fluorescein isothiocyanate dextranIBA 01/2018
1	Claudin-4IBA 01/2018
1	OccludinIBA 01/2018
1	CollagenIBA 11/2017
1	SterolsIBA 11/2017
1	Carrier Proteins (Binding Protein)IBA 11/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 07/2017
1	Peptides (Polypeptides)IBA 07/2017
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 07/2017
1	Tyrosine (L-Tyrosine)FDA Link 05/2017
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 05/2017
1	Sodium-Hydrogen Exchanger 3IBA 12/2015
1	Glucose (Dextrose)FDA LinkGeneric 06/2015
1	Polysaccharides (Glycans)IBA 06/2015
1	Ezetimibe (Zetia)FDA Link 01/2012
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 12/2011
1	Biological ProductsIBA 07/2011
1	CurcuminIBA 07/2011
1	Streptozocin (Streptozotocin)FDA Link 10/2010
1	Insulin (Novolin)FDA Link 10/2010
1	bile acid binding proteinsIBA 10/2010
1	Guanylate KinasesIBA 04/2010
1	Platelet Activating FactorIBA 04/2010
1	Cholera ToxinIBA 02/2010
1	Type III Secretion SystemsIBA 12/2009

Therapy/Procedure

1	Therapeutics 01/2019
1	Intraperitoneal Injections 10/2010
1	Drug Therapy (Chemotherapy) 12/2009